CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Andy Plump, architect of Takeda’s R&D overhaul, to retire next year

Neutral
AI Analysis

Summary

Andy Plump, who led Takeda's R&D overhaul and focused the company on biotech collaborations, is retiring next year. CEO Julie Kim credited him with establishing a lasting foundation for the company's research strategy.

Importance:2/10
Sentiment:
0.00
management changeexecutive retirementR&D
Related Companies

Read the original article

Published by BioPharma Dive on September 10, 2026 3:24 PM

Read Original